Seoul, South Korea

Do Seok Hwang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hk Inno.n Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Do Seok Hwang. Retrieved from https://idiyas.com/inventor/do-seok-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Do Seok Hwang, Inventor in Seoul

Introduction

Do Seok Hwang is an inventor based in Seoul, South Korea. He is associated with HK inno.N Corporation and has 1 patent listed in the provided information.

Latest Patents

Hwang’s patent, “Crystalline Form of Heterocyclic Compound as Protein Kinase Inhibitor,” concerns a crystalline form of a heterocyclic compound intended for use as a protein kinase inhibitor. The compound is N-(4-(1-(2-cyanoacetyl)-3-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-6-yl)cyclopropanecarboxamide.

Career Highlights

Hwang’s listed invention relates to pharmaceutical research and the development of a crystalline form of a compound with potential protein kinase inhibitor applications. The provided information identifies HK inno.N Corporation as his company.

Collaborations

Young Ju Kim and Jae Hong Kweon are identified as Hwang’s coworkers.

Conclusion

Do Seok Hwang’s listed patent reflects his contribution to research on crystalline pharmaceutical compounds and protein kinase inhibitors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…